| scholarly article | Q13442814 |
| P2093 | author name string | Giang Nguyen | |
| Cassandra L Smith | |||
| Andrew Bolton | |||
| P2860 | cites work | A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs | Q41009556 |
| Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. | Q41102243 | ||
| Fragile sites and cancer breakpoints | Q41429073 | ||
| Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis | Q41731713 | ||
| Chronic marginal iron intakes during early development in mice alter brain iron concentrations and behavior despite postnatal iron supplementation | Q41751553 | ||
| In silico experimentation with a model of hepatic mitochondrial folate metabolism. | Q41763852 | ||
| Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark | Q42606379 | ||
| Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment | Q42663078 | ||
| Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism | Q43227733 | ||
| Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning | Q43598274 | ||
| A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder | Q44238383 | ||
| A mathematical model of the methionine cycle | Q44668482 | ||
| Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation | Q44860138 | ||
| Folic acid and folates. Preface | Q46356491 | ||
| Effect of catechol-O-methyltransferase val158met genotype on attentional control. | Q46497177 | ||
| Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. | Q46627680 | ||
| Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults | Q46651810 | ||
| Long-range allosteric interactions between the folate and methionine cycles stabilize DNA methylation reaction rate | Q46902840 | ||
| The association of age and semen quality in healthy men. | Q46954552 | ||
| The Dutch famine and schizophrenia spectrum disorders | Q47611296 | ||
| Imprinting of high sensitivity to a high-cholesterol diet by nutrition in early life | Q47676377 | ||
| The influence of paternal age on down syndrome | Q47880376 | ||
| Multicolor fluorescent in situ hybridization on post-mortem brain in schizophrenia as an approach for identification of low-level chromosomal aneuploidy in neuropsychiatric diseases. | Q48693074 | ||
| The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1. | Q51899086 | ||
| Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia | Q22248085 | ||
| Copy-number variations associated with neuropsychiatric conditions | Q22251090 | ||
| Rare chromosomal deletions and duplications increase risk of schizophrenia | Q22337245 | ||
| A family of human zinc finger proteins that bind methylated DNA and repress transcription | Q24298802 | ||
| Reelin promoter hypermethylation in schizophrenia | Q24531469 | ||
| Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation | Q24533431 | ||
| Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain | Q24534089 | ||
| Paternal age and sporadic schizophrenia: evidence for de novo mutations | Q24604993 | ||
| Histone modifications, DNA methylation, and schizophrenia | Q24606593 | ||
| Common variants conferring risk of schizophrenia | Q24614376 | ||
| Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation | Q24629022 | ||
| Prenatal nutritional deficiency and risk of adult schizophrenia | Q24643484 | ||
| Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder | Q24652360 | ||
| Epigenetic mediation of environmental influences in major psychotic disorders | Q24652697 | ||
| Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia | Q24653951 | ||
| Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism | Q24656561 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| Spontaneous mutation and parental age in humans | Q24676048 | ||
| The genetics of schizophrenia | Q24815806 | ||
| Worms gang up on bacteria | Q27860588 | ||
| Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction | Q28131789 | ||
| Effects of male age on semen quality and fertility: a review of the literature | Q28199923 | ||
| The origins, patterns and implications of human spontaneous mutation | Q28206110 | ||
| Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells | Q28239651 | ||
| Epigenetics of autism spectrum disorders | Q28264503 | ||
| Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia | Q28274064 | ||
| A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence | Q28284112 | ||
| Genomic DNA methylation: the mark and its mediators | Q28290773 | ||
| Chromosomal fragile site expression in Turkish psychiatric patients. | Q51912153 | ||
| Chromosomal fragile sites in schizophrenic patients. | Q51913560 | ||
| Long repeat tracts at SCA8 in major psychosis. | Q51971352 | ||
| Chromosomal fragile site expression in lymphocytes from patients with schizophrenia. | Q51987815 | ||
| Detection of the fragile X chromosome and other fragile sites. | Q52687512 | ||
| Development. There's something curious about paternal-age effects | Q56355116 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| DNA stability and schizophrenia in twins | Q57319305 | ||
| Advancing paternal and maternal age are both important for autism risk | Q59640156 | ||
| Neurodegeneration mediated by chromosome instability suggests changes in strategy for therapy development in ataxia-telangiectasia | Q62066078 | ||
| Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome | Q68219647 | ||
| Fragile sites and chromosome breakpoints in constitutional rearrangements I. Amniocentesis | Q70615507 | ||
| Targeting the fungal plasma membrane proton pump | Q71643115 | ||
| Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype | Q73163014 | ||
| Comparison of the number of triplets in SCA1, MJD/SCA3, HD, SBMA, DRPLA, MD, FRAXA and FRDA genes in schizophrenic patients and a healthy population | Q73307658 | ||
| The fragile X syndrome and other fragile site disorders | Q74790217 | ||
| The applicability of the flow cytometric sperm chromatin structure assay in epidemiological studies. Asclepios | Q77525169 | ||
| A study of schizophrenia in the male: a psychiatric and social study based on 138 cases with follow up | Q78411437 | ||
| Detection and interpretation of altered methylation patterns in cancer cells | Q81416192 | ||
| Folic acid and psychopathology | Q38717159 | ||
| Paternal age and the risk of birth defects in offspring | Q28293898 | ||
| Glucocorticoid-induced DNA demethylation and gene memory during development | Q28362233 | ||
| Sperm count and chromatin structure in men exposed to inorganic lead: lowest adverse effect levels | Q28393478 | ||
| A genome-wide association study in 574 schizophrenia trios using DNA pooling | Q28943536 | ||
| Orthomolecular Psychiatry: Varying the concentrations of substances normally present in the human body may control mental disease | Q29039975 | ||
| Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
| New nomenclature for chromatin-modifying enzymes | Q29616425 | ||
| Autism spectrum disorders: developmental disconnection syndromes | Q29616818 | ||
| DNA methylation landscapes: provocative insights from epigenomics | Q29617144 | ||
| The DNA methyltransferases of mammals | Q29617317 | ||
| Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins | Q30460498 | ||
| Aneuploidy and confined chromosomal mosaicism in the developing human brain. | Q33288955 | ||
| Molecular cytogenetics and cytogenomics of brain diseases | Q33464340 | ||
| CpG island methylator phenotypes in aging and cancer. | Q33765672 | ||
| Seasonality and infectious disease in schizophrenia: the birth hypothesis revisited | Q33813135 | ||
| Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? | Q33870188 | ||
| The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm | Q33906096 | ||
| The NOTCH4 locus is associated with susceptibility to schizophrenia | Q33912810 | ||
| Chromosomal abnormalities and schizophrenia | Q33920498 | ||
| Advancing paternal age and the risk of schizophrenia | Q33941943 | ||
| Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence | Q33962308 | ||
| Nutrition in embryonic and fetal development | Q33975693 | ||
| Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis | Q33990192 | ||
| Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. | Q33996709 | ||
| Epigenetic gene deregulation in cancer. | Q34097482 | ||
| Genetics of schizophrenia and the new millennium: progress and pitfalls | Q34136656 | ||
| Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring | Q34143026 | ||
| Fragile and unstable chromosomes in cancer: causes and consequences | Q34264402 | ||
| Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder | Q34331509 | ||
| A mathematical model of the folate cycle: new insights into folate homeostasis | Q34360712 | ||
| Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism | Q34374496 | ||
| The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect | Q34380582 | ||
| Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report | Q34395443 | ||
| Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations | Q34436816 | ||
| Potential mechanisms of metabolic imprinting that lead to chronic disease | Q34492865 | ||
| Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond | Q34494146 | ||
| Folate supplementation: too much of a good thing? | Q34496643 | ||
| The genetic deconstruction of psychosis | Q34634774 | ||
| Maternal nutrition--effect on fetal growth and outcome of pregnancy | Q34660255 | ||
| NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. | Q34690936 | ||
| Schizophrenia: a concise overview of incidence, prevalence, and mortality | Q34778618 | ||
| Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism | Q34895200 | ||
| Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain | Q34979102 | ||
| One-carbon metabolism and schizophrenia: current challenges and future directions. | Q35011748 | ||
| Heritable fragile sites on human chromosomes. IX. Population cytogenetics and segregation analysis of the BrdU-requiring fragile site at 10q25. | Q35202457 | ||
| Dear old dad. | Q35635249 | ||
| Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders | Q35956872 | ||
| Psychiatric genetics: a methodologic critique | Q35996372 | ||
| Homocysteine and folate metabolism in depression | Q36234417 | ||
| Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? | Q36242647 | ||
| Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines | Q36309199 | ||
| Immunological findings in autism | Q36411543 | ||
| Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer | Q36657641 | ||
| Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder | Q36736904 | ||
| New twists in X-chromosome inactivation. | Q36801044 | ||
| Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability | Q36983629 | ||
| Mammalian DNA methyltransferases: a structural perspective | Q37002199 | ||
| Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism | Q37029453 | ||
| Chromosomal mosaicism goes global | Q37034021 | ||
| Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics. | Q37346195 | ||
| Nuclear and mitochondrial genome defects in autisms | Q37372830 | ||
| Schizophrenia genetics: advancing on two fronts | Q37432739 | ||
| CpG islands--'a rough guide'. | Q37450048 | ||
| Fragile X syndrome: from molecular genetics to therapy. | Q37590581 | ||
| DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. | Q37618053 | ||
| MicroRNAs in psychiatric and neurodevelopmental disorders | Q37730250 | ||
| DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. | Q38325560 | ||
| General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells | Q38346570 | ||
| Characterisation of site-biased DNA methyltransferases: specificity, affinity and subsite relationships | Q38363464 | ||
| P433 | issue | 6 | |
| P921 | main subject | autism | Q38404 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 447-469 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Current Genomics | Q5195047 |
| P1476 | title | Genomic and epigenomic instability, fragile sites, schizophrenia and autism | |
| P478 | volume | 11 |
| Q33925250 | A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder |
| Q53420766 | Behavioral Variability and Somatic Mosaicism: A Cytogenomic Hypothesis. |
| Q35683865 | Brain in flames - animal models of psychosis: utility and limitations |
| Q46859945 | Conference scene: 2nd cancer epigenetics conference |
| Q30300009 | DNA secondary structure at chromosomal fragile sites in human disease |
| Q84273227 | Decoding the genome beyond sequencing: the new phase of genomic research |
| Q36929329 | Dietary Patterns of Children with Autism Spectrum Disorder: A Study Based in Egypt |
| Q30558941 | Epidemiology and genetics of common mental disorders in the general population: the PEGASUS-Murcia project |
| Q64076067 | Epigenetic Regulations in Neuropsychiatric Disorders |
| Q35647831 | Fitness Consequences of Advanced Ancestral Age over Three Generations in Humans |
| Q64389728 | Fragility Extraordinaire: Unsolved Mysteries of Chromosome Fragile Sites |
| Q48326149 | Genetic and Developmental Perspective of Language Abnormality in Autism and Schizophrenia: One Disease Occurring at Different Ages in Humans? |
| Q33729022 | Genetics of schizophrenia from a clinicial perspective. |
| Q35813095 | Genome-wide copy-number variation study of psychosis in Alzheimer's disease. |
| Q30453993 | Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders |
| Q38781083 | Insight into the ERVK Integrase - Propensity for DNA Damage |
| Q36169475 | Long contiguous stretches of homozygosity spanning shortly the imprinted loci are associated with intellectual disability, autism and/or epilepsy |
| Q36939187 | Morphometric Analysis of Recognized Genes for Autism Spectrum Disorders and Obesity in Relationship to the Distribution of Protein-Coding Genes on Human Chromosomes |
| Q64949793 | Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism. |
| Q36367450 | Paradox of schizophrenia genetics: is a paradigm shift occurring? |
| Q26744368 | Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology |
| Q38020256 | Recent advances in nutrition, genes and brain health |
| Q36682494 | Role of DNA secondary structures in fragile site breakage along human chromosome 10 |
| Q58580294 | The FRA14B common fragile site maps to a region prone to somatic and germline rearrangements within the large GPHN gene |
| Q38852303 | The altered promoter methylation of oxytocin receptor gene in autism |
| Q50301196 | Untangling the most probable role for vitamin D3 in autism |
Search more.